Related Experiment Video
Updated: Dec 19, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma
Alexander Cox1, Chenming Zhao2, Yuri Tolkach3
1Department of Urology, University Hospital Bonn, Bonn, Germany Alexander.Cox@ukbonn.de.
Background/Aim:
Myoferlin (MYOF) has emerged as an oncogenic protein in various human cancer types. This study was conducted to investigate comprehensively the expression and functional properties of MYOF in clear-cell renal-cell carcinoma (ccRCC) with respect to its value as diagnostic biomarker and therapeutic target.
Materials And Methods:
mRNA and protein expression of MYOF were assessed by quantitative polymerase chain reaction and immunohistochemistry. siRNA-mediated knockdown of MYOF was performed in the RCC cell line ACHN followed by proliferation, migration and invasion assays.
Results:
MYOF mRNA and protein expression were significantly up-regulated in ccRCC. Higher mRNA levels were measured in advanced tumors. MYOF protein expression was increased in tumors with higher histological grades, and those with positive lymph node and surgical margin status. MYOF knockdown led to reduction of migration and invasion in ACHN cells, whereas expression of angiogenesis-associated genes tyrosine-protein kinase receptor-2 (TIE2), angiopoietin 2 (ANG2) and caveolin-1 (CAV1) was up-regulated following knockdown.
Conclusion:
MYOF may serve as a diagnostic biomarker of tumor progression and a potential therapeutic target in ccRCC.
Insights
Myoferlin (MYOF) is elevated in clear-cell renal-cell carcinoma (ccRCC), indicating its potential as a diagnostic biomarker for tumor progression and a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Myoferlin (MYOF) is an oncogenic protein implicated in various human cancers.
- Its role in clear-cell renal-cell carcinoma (ccRCC) requires comprehensive investigation.
Purpose of the Study:
- To investigate MYOF expression and function in ccRCC.
- To evaluate MYOF as a diagnostic biomarker and therapeutic target for ccRCC.
Main Methods:
- Assessed MYOF mRNA and protein expression using quantitative PCR and immunohistochemistry.
- Performed siRNA-mediated MYOF knockdown in ACHN cells.
- Conducted proliferation, migration, and invasion assays post-knockdown.
Main Results:
- MYOF mRNA and protein were significantly upregulated in ccRCC, correlating with advanced tumor stage, higher grade, and positive lymph node/surgical margin status.
- MYOF knockdown reduced migration and invasion in ACHN cells.
- Knockdown led to upregulation of angiogenesis-associated genes TIE2, ANG2, and CAV1.
Conclusions:
- MYOF is a potential diagnostic biomarker for ccRCC tumor progression.
- MYOF represents a promising therapeutic target for ccRCC treatment.
Related Concept Videos
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Cancer Cell Migration through Invadopodia
Cytoskeletal Coordination in Cell Migration
Cell Migration
Cell Migration

